Wednesday, February 27, 2013
United Therapeutics Corp., of Silver Spring, Md., reported total revenues of $243.8 million for the fourth quarter, with net income totaling $83.3 million, or $1.65 per share. Those figures were well above consensus estimates, which had predicted $233 million in revenue and earnings per share of $1.25.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.